-46.5%
APLD vs GSK
+14.9%
-61.4%
-67.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.7% | +5.0% | -11.8% | -4.1% |
| 7D | -18.5% | +4.9% | -23.5% | -16.2% |
| 30D | -32.8% | +9.9% | -42.6% | -29.2% |
| 3M | -46.9% | +0.2% | -47.0% | -45.6% |
| 6M | -53.4% | +2.3% | -55.7% | -51.9% |
| YTD | -32.3% | +7.1% | -39.3% | -20.1% |
| 1Y | -46.5% | +13.1% | -59.6% | -32.6% |
| All | -46.5% | +14.9% | -61.4% | -32.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling